BioSight, a medical technology start-up, has developed a technology that enables leukemia patients to avoid the worst effects of chemotherapy.
“Our interim results in a major study of patients with leukemia shows that our system yields the maximum efficiency from chemo, with a minimum of toxicity,” said Dr. Ruth Ben Yakar, CEO of BioSight. “Our method of using chemo does not cause brain damage or weaken blood cells,” with all its attendant phenomena, such as lethargy, loss of hair, etc.
BioSight’s “Trojan horse” chemo technology doesn’t only work for leukemia patients, said Ben Yakar. “We believe it will be effective in many other kinds of cancer as well. It’s a matter of finding the amino acid that a specific cancer is ‘allergic’ to, and packaging it in a structure that the cancer cell thinks contains material that strengthens it, while in reality it contains material that destroys it.”
The technology, said Ben Yakar, could become very important in the field of cancer treatment.”This really could be the cure for cancer.”
BioSight was one of a dozen start-ups that presented their technology at the annual Go4Israel conference in Tel Aviv Monday. Considered one of the most important gatherings of international investors in Israel, the conference discussed issues relevant to investors and start-ups, including raising funds and establishing strategic alliances between corporate, entrepreneurs and investors from around the world. Companies presenting at the event included firms in high-tech, life sciences, renewable energy, and others. Among the investors was a large delegation from Europe – particularly France – and from China.
The Chinese presence in particular was noticeable, said conference chairman Edouard Cukierman, who heads the Cukierman & Co. Investment House and is Managing Partner of Catalyst Funds.
“With an increasing presence of Chinese investors at the Go4Israel conference, which are now the world leaders in investments in Israel, we can help open new global opportunities and create new relationships between entrepreneurs and international investors. Israel as a country and Israelis as business partners have a lot to offer worldwide.”
Read more at Times of Israel.